INTERNATIONAL PATENT: BAYER AKTIENGESELLSCHAFT, ASKLEPIOS BIOPHARMACEUTICAL, INC. FILES APPLICATION FOR "NOVEL IGM AND IGG CLEAVING ENZYMES"

GENEVA, Dec. 22 -- BAYER AKTIENGESELLSCHAFT (Kaiser-Wilhelm-Allee 151373 Leverkusen), ASKLEPIOS BIOPHARMACEUTICAL, INC. (20 T. W. Alexander Drive, Suite 110Research Triangle Park, North Carolina 27709) filed a patent application (PCT/EP2025/065427) for "NOVEL IGM AND IGG CLEAVING ENZYMES" on Jun 04, 2025. With publication no. WO/2025/256977, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KENSCH, Oliver (c/o Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee 151373 Leverkusen), BRAKE, Anja (c/o Bayer Aktiengesellschaft, Kaise...